FIELD: medicine.
SUBSTANCE: for thrombocyte dysfunction treatment at the background of arterial hypertension (AH) with metabolic syndrome (MS), complex therapy is performed for 24 weeks, including individual hypocalorific diet and introduction of delayed-release verapamil in amount of 180 mg once each morning and of trandolapril in amount of 2 mg once each morning.
EFFECT: thrombocyte function normalisation for patients with AH with MS due to therapeutic effect potentiation of separate components in complex therapy.
1 ex
Authors
Dates
2009-01-27—Published
2007-02-19—Filed